Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment

被引:28
|
作者
Urbanova, Barbora Soukupova [1 ]
Schwabova, Jaroslava Paulasova [1 ]
Magerova, Hana [1 ]
Jansky, Petr [1 ]
Markova, Hana [1 ,2 ]
Vyhnalek, Martin [1 ,2 ]
Laczo, Jan [1 ,2 ]
Hort, Jakub [1 ,2 ]
Tomek, Ales [1 ]
机构
[1] Charles Univ Prague, Motol Univ Hosp, Fac Med 2, Dept Neurol, Prague, Czech Republic
[2] St Annes Univ, Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic
关键词
Alzheimer's disease; breath-holding index; cerebrovascular reserve capacity; microangiopathy; mild cognitive impairment; transcranial color-coded sonography; transcranial Doppler; BLOOD-FLOW-VELOCITY; TRANSCRANIAL DOPPLER ULTRASOUND; BRAIN PERFUSION SPECT; E EPSILON-4 ALLELE; BODY-MASS INDEX; VASOMOTOR REACTIVITY; VASCULAR DEMENTIA; APOLIPOPROTEIN-E; CEREBRAL VASOREACTIVITY; VASODILATORY STIMULUS;
D O I
10.3233/JAD-170815
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral microangiopathy in Alzheimer's disease (AD) causes chronic hypoperfusion and probably accelerates neurodegenerative changes. Objective: We hypothesize microvascular impairment could be present already in mild cognitive impairment (MCI) and can be revealed using transcranial color-coded sonography (TCCS) and the breath-holding maneuver. Methods: Three groups of subjects (AD in the stage of dementia, MCI, and cognitively normal controls) with detailed neuropsychological testing and low cerebrovascular burden (no history of stroke, no intra- or extracranial artery stenoses, and no severe vascular lesions on brain MRI), underwent a TCCS assessment of peak systolic (PSV), mean flow (MFV), and end diastolic velocities (EDV) and resistance and pulsatility indices (RI, PI) in large intracranial vessels bilaterally. Cerebrovascular reserve capacity was assessed using the breath-holding index (BHI) in middle cerebral artery (MCA) bilaterally. The ultrasound parameters were compared between the groups, correlated with neuropsychological tests, and compared between amnestic and non-amnestic MCI subtypes. Results: Fourteen AD (3 males, 67.9 +/- 11.1 years, MMSE 18.0 +/- 4.6), 24 MCI (13 males, 71.9 +/- 7.3 years, MMSE 28.0 +/- 1.6), and 24 risk factor-matched controls (14 males, 67.8 +/- 6.4 years, MMSE 29.1 +/- 1.2) were enrolled. Significant differences were found between AD and controls in MFV, EDV, RI, PI in right MCA after breath holding, in PSV, MFV, EDV in left MCA after breath holding, and in BHI on the left side. The left BHI correlated positively with verbal memory test. Conclusion: Results show decreased cerebrovascular reserve capacity in AD as a sign of impaired cerebral hemodynamic status without severe underlying atherosclerosis. This can be identified using TCCS and BHI.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [21] Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
    Weilin Liu
    Huawei Lin
    Xiaojun He
    Lewen Chen
    Yaling Dai
    Weiwei Jia
    Xiehua Xue
    Jing Tao
    Lidian Chen
    Translational Psychiatry, 10
  • [22] Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment
    Mangialasche, Francesca
    Baglioni, Mauro
    Cecchetti, Roberta
    Kivipelto, Miia
    Ruggiero, Carmelinda
    Piobbico, Danilo
    Kussmaul, Lothar
    Monastero, Roberto
    Brancorsini, Stefano
    Mecocci, Patrizia
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 649 - 660
  • [23] Staged decline of visual processing capacity in mild cognitive impairment and Alzheimer's disease
    Bublak, Peter
    Redel, Petra
    Sorg, Christian
    Kurz, Alexander
    Foerstl, Hans
    Mueller, Hermann J.
    Schneider, Werner X.
    Finke, Kathrin
    NEUROBIOLOGY OF AGING, 2011, 32 (07) : 1219 - 1230
  • [24] FMRI in mild cognitive impairment and Alzheimer's disease
    Rombouts, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S49 - S49
  • [25] Mild cognitive impairment: Aging to Alzheimer's disease
    Heilbronner, RL
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (05) : 718 - 722
  • [26] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [27] The fornix in mild cognitive impairment and Alzheimer's disease
    Nowrangi, Milap A.
    Rosenberg, Paul B.
    FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [28] Mild cognitive impairment and preclinical Alzheimer's disease
    Morris, JC
    GERIATRICS-US, 2005, : 9 - 14
  • [29] Dysgraphia in Alzheimer's disease with mild cognitive impairment
    Kavrie, S
    Neils-Strunjas, J
    JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2002, 10 (01) : 73 - 85
  • [30] Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment
    Switzer, Aaron R.
    Cheema, Ikreet
    McCreary, Cheryl R.
    Zwiers, Angela
    Charlton, Anna
    Alvarez-Veronesi, Ana
    Sekhon, Ramnik
    Zerna, Charlotte
    Stafford, Randall B.
    Frayne, Richard
    Goodyear, Bradley G.
    Smith, Eric E.
    NEUROLOGY, 2020, 95 (10) : E1333 - E1340